Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies

Apr 24, 2023

01:16:22

Emile Nuwaysir, CEO of Boston-based Ensoma, on developing off-the-shelf in vivo gene editing therapies.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.